A further analysis of the estimated currency exposure of assets is provided in note 29.
Permira Funds have been included in Europe, which is the primary focus of such funds, although they can invest a significant amount of their committed capital in businesses which do not have significant activities in Europe.
SV Life Sciences Fund II, SV Life Sciences Fund III and SV Life Sciences Fund IV have been included within the US.
In 2008 they were included as current assets rather than as part of the investment portfolio.
It remains the Companys intention to sell or transfer these assets.
Private equity funds of funds are relatively equally focused between Europe and the US.
